Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Detalles Bibliográficos
Autores principales: Wang, Jeffrey, Wang, Jacqueline, Lopez, Elyse, Guo, Hui, Zhang, Hui, Liu, Yang, Chen, Zhihong, Huang, Shengjian, Zhou, Shouhao, Leeming, Angela, Zhang, R. J., Jung, Dayoung, Shi, Hannah, Grundman, Hadley, Doakes, Darian, Cui, Kathleen, Jiang, Changying, Ahmed, Makhdum, Nomie, Krystle, Fang, Bingliang, Wang, Michael, Yao, Yixin, Zhang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812/
https://www.ncbi.nlm.nih.gov/pubmed/31780660
http://dx.doi.org/10.1038/s41408-019-0259-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812/
https://www.ncbi.nlm.nih.gov/pubmed/31780660
http://dx.doi.org/10.1038/s41408-019-0259-8

Ejemplares similares